EBNA-1 Protein (562-570) FMVFLQTHI

EBNA-1 Protein (562-570) FMVFLQTHI


Artikel-Nr.: P2301.9501

Shipping: Shipment: not cooled. Store at -20°C. For laboratory usage only!

Lieferzeit: 3 - 8 Werktage
Für genaue Informationen zum Liefertermin wenden Sie sich bitte an Genaxxon.

Menge Stückpreis
bis 2 145,00 € *
ab 3 116,00 € *

Gewicht:

Wählen Sie bitte die gewünschte Packungsgröße aus.

Reinheit:

Wählen Sie bitte die gewünschte Reinheit aus.

The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virus of the herpes... mehr
Produktinformationen "EBNA-1 Protein (562-570) FMVFLQTHI"

The Epstein-Barr virus (EBV), also called Human herpes virus 4 (HHV-4), is a virus of the herpes family (which includes Herpes simplex virus and Cytomegalo virus).

On infecting the B-lymphocyte, the linear virus genome circularizes and the virus subsequently persists within the cell as an episome. The virus can execute several distinct programs of gene expression which can be broadly categorized as being lytic cycle or latent cycle. The lytic cycle or productive infection results in staged expression of a host of viral proteins with the ultimate objective of producing infectious virions. Formally, this phase of infection does not inevitably lead to lysis of the host cell as EBV virions are produced by budding from the infected cell. The latent cycle (lysogenic) programs are those that do not result in production of virions.

A very limited, distinct set of viral proteins are produced during latent cycle infection. These include Epstein-Barr nuclear antigen (EBNA)-1, EBNA-2, EBNA-3A, EBNA-3B, EBNA-3C, EBNA-leader protein (EBNA-LP) and latent membrane proteins (LMP)-1, LMP-2A and LMP-2B and the Epstein-Barr encoded RNAs (EBERs).

Weitere Artikel passend zu "EBNA-1 Protein (562-570) FMVFLQTHI"
Specifications: Purity: >95% (HPLC) Sequence: FMVFLQTHI Lyophilized powder mehr
 

Technische Daten:

Specifications:
Purity: >95% (HPLC)
Sequence: FMVFLQTHI
Lyophilized powder

Applikation:

T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response

Quelle

synthetic

Sicherheits Hinweise / Safety

Klassifizierungen / Classification

eclass-Nr: 32-16-04-09
Dokumente - Protokolle - Downloads mehr


Dokumente - Protokolle - Downloads

Hier finden Sie Informationen und weiterführende Literatur zu EBNA-1 Protein (562-570) FMVFLQTHI. Für weitere Dokumente (Zertifikate mit weiteren Lotnummern, Sicherheitsdatenblätter in anderer Sprache, weitere Produktinformationen) wenden Sie sich bitte an Genaxxon biosience unter: info@genaxxon.com oder Tel.: +49 731 3608 123.

 
 
 
Literatur .... mehr

Referenzen..

Hier finden Sie Artikel und Literaturzitate, in denen die Autoren auf die hohe Qualität dieses Genaxxonprodukts vertrauen.
Listed below are articles and references, in which the authors trust in the high quality of this Genaxxon product.

Quelle/Source: NCBI PubMed >

TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation
Dominik Wieland, Janine Kemming, Anita Schuch, Florian Emmerich, Percy Knolle, Christoph Neumann-Haefelin, Werner Held, Dietmar Zehn, Maike Hofmann, Robert Thimme
Nat Commun. 2017; 8: 15050. Published online 2017 May 3. doi: 10.1038/ncomms15050
PMCID: PMC5418623